SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Escalating U.S.-Iran tensions, Strait of Hormuz disruptions and rising fuel costs dominate discussion around DJT, with traders focused on the potential impact on inflation, interest rates and the broader economy. Supporters portray Trumps posture and reported diplomatic efforts as wins, while critics blame the conflict and possible further escalation for worsening energy and market risks.

NEAR Protocol is the blockchain for AI. A high-performance, AI-native platform built to power the next generation of decentralized applications and intelligent agents. It provides the infrastructure AI needs to transact, operate, and interact across Web2 and Web3. NEAR combines three core elements: User-Owned AI, which ensures agents act in users’ best interests; Intents and Chain Abstraction, which eliminate blockchain complexity for seamless, goal-driven transactions across chains; and a sharded blockchain architecture that delivers the scalability, speed, and low-cost execution needed for real-world AI and Web3 use. This integrated stack makes NEAR the foundation for building secure, user-owned, AI-native applications at internet scale.

Near

Traders are linking NEARs sharp rally to the launch of confidential perpetual contracts powered by Hyperliquid, with privacy-focused leveraged trading emerging as the immediate catalyst. The move has strengthened bullish discussion around NEARs AI, agent and cross-chain infrastructure, though some traders view the surge as momentum- or liquidity-driven and warn of a pullback.

Uranium Energy Corp. engages in the provision of uranium and titanium mining and related activities, including exploration, pre-extraction, extraction, and processing of uranium concentrates, and titanium minerals. It operates through the following geographical segments: Wyoming, Texas, Saskatchewan, and Others. The company was founded by Alan P. Lindsay and Amir Adnani on May 16, 2003 and is headquartered in Corpus Christi, TX.

Uranium Energy Corp

Recent quarterly results showing no uranium sales and a wider loss have put UEC under pressure, with traders questioning its valuation, production pace and near-term revenue. Bulls counter that the company is preserving inventory for potentially higher uranium prices and has substantial liquidity, no debt and expanding U.S. production tied to the broader nuclear-energy demand theme.

Avalanche is a high throughput smart contract blockchain&nbsp;platform. Validators secure the network through a proof-of-stake consensus protocol. It is said to be fast, low cost, and environmental friendly.

Avalanche

Reports of institutional and real-world-asset adoption, particularly NYSE testing Avalanche for a tokenized-securities platform, are driving renewed attention alongside strong volume and broader altcoin rotation. Traders are largely bullish on the momentum and Avalanches tokenization prospects, though others view the move as a speculative pump and remain concerned about weak follow-through and token inflation.

MP Materials Corp. engages in the production and marketing of rare earth specialty materials. It operates through the following segments: Materials and Magnetics. The Materials segment focuses on the operation of Mountain Pass, which produces refined rare earth oxides and related products, as well as rare earth concentrate products. The Magnetics segment is involved in the operation of Independence Facility, where the company began production of magnetic precursor products. The company was founded by James Henry Litinsky and Michael Rosenthal in 2017 and is headquartered in Las Vegas, NV.

MP Materials Corporation

ChinaU.S. tensions over rare-earth exports and negotiations are driving attention to MP, alongside continued discussion of its government-backed domestic mine-to-magnet expansion and planned GM magnet deliveries. Traders are divided between a bullish view that supply-chain restrictions and U.S. support strengthen MPs strategic position and concerns that a China deal or broader weakness could pressure the stock in the near term.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

A reported U.S.-Denmark-Greenland security agreement has put CRMLs Tanbreez rare-earth project at the center of renewed critical-minerals speculation, with traders viewing restrictions on Chinese and Russian investment as a strategic tailwind. Bullish participants expect sector momentum and possible short covering, while skeptics note the agreement is not a direct mining, funding, or permitting commitment and does not change the projects development timeline.

Cleveland-Cliffs, Inc. is a flat-rolled steel company, which engages in provision of iron ore pellets to the North American steel industry. It focuses on the production of metallic and coke, iron making, steelmaking, rolling and finishing, and downstream tubular components, stamping, and tooling. It operates through the Steelmaking and Other Businesses segments. The company was founded in 1847 and is headquartered in Cleveland, OH.

Cleveland-Cliffs Inc

Improving steel-cycle expectations, higher HRC prices, and managements stronger second-half outlook after Q2 results are driving attention, with traders also focused on a potential POSCO strategic partnership. Bulls see improving cash flow and short-covering potential, while bears cite heavy debt, cyclical pricing risk, and the lack of a confirmed deal.

Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Intuitive Surgical Inc

A strong quarterly report was overshadowed by slower U.S. procedure growth and a cautious outlook, prompting a sharp selloff and renewed valuation concerns. Traders are divided between viewing the decline as an overreaction and buying opportunity versus warning that competition, pricing pressure, tariffs, and GLP-1-related demand risks justify a broader reset.

StarkNet is a permissionless decentralized Layer 2 (L2) validity rollup, built to allow Ethereum to scale via cryptographic protocols called STARKs, without compromising Ethereum’s core principles of decentralization, transparency, inclusivity and security. The StarkNet Token is needed to operate the ecosystem, maintain and secure it, decide on its values and strategic goals, and direct its evolution. This token will be required for (i) governance, (ii) payment of transaction fees on StarkNet, and (iii) participation in StarkNet’s consensus mechanism.

Starknet

Starknets privacy and BitcoinFi pushparticularly the rollout of strkBTC and STRK20 for shielded Bitcoin and ERC-20 transactionsis driving attention, alongside its post-quantum STARK technology. Traders are bullish on the differentiated infrastructure and growing ecosystem activity, while others remain cautious about token-unlock-related selling pressure and weak price structure.

General Motors Co. engages in the designing, manufacturing, and selling of trucks, crossovers, cars, and automobile parts, and in providing software-enabled services and subscriptions. It operates through the following segments: GMNA, GMI, Cruise, and GM Financial. The company was founded by William C. Durant on September 16, 1908 and is headquartered in Detroit, MI.

General Motors Company

Renewed concerns over potential 50% U.S. tariffs on Canadian vehicles, parts and steel are driving debate around GMs margins and North American supply chain. Traders are also weighing high rates, oil prices, weak EV demand and possible engine-recall costs against bullish views on buybacks, earnings strength and technical support.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Zipalertinib Plus Chemotherapy Demonstrates 6-Month Median Progression-Free Survival Benefit in REZILIENT3 Phase 3 Trial in First-Line EGFR Exon 20 Insertion Mutation Non-Small Cell Lung Cancer

Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd., and Cullinan Therapeutics, Inc. (Nasdaq: CGEM) today announced results from the Phase 3 REZILIENT3 trial evaluating zipalertinib plus chemotherapy versus chemotherapy alone in the first-line treatment of patients with epidermal growth factor...

Zipalertinib Plus Chemotherapy First-Line Phase 3 REZILIENT3 Trial Data Selected for Presidential Symposium Presentation at the IASLC 2026 World Conference on Lung Cancer

Taiho Oncology, Inc. and Cullinan Therapeutics, Inc. (Nasdaq: CGEM) today announced that results from the planned interim analysis of the Phase 3 REZILIENT3 trial have been selected for presentation in the Presidential Symposium 2 at the International Association for the Study of Lung Cancer's...

Zipalertinib Plus Chemotherapy Meets Primary Endpoint of Progression-Free Survival in Planned Interim Analysis of Phase 3 REZILIENT3 Trial in First-Line EGFR Exon 20 Insertion Mutation Non-Small Cell Lung Cancer

Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd., and Cullinan Therapeutics, Inc. (Nasdaq: CGEM) today announced that the REZILIENT3 trial, a global Phase 3 clinical trial evaluating the combination of zipalertinib and platinum-based chemotherapy compared with chemotherapy alone in the...

Why Marvell Technology Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket

href=https://www.benzinga.com/quote/RMSG target=_blank>(NASDAQ: RMSG) lost 67.6% to $0.69 in pre-market trading. The company recently announced a 1-for-20 reverse stock split.The shares of Marvell Technology Inc (NASDAQ: MRVL) surged in pre-market trading after securing a spot in the S&P 500...

Upcoming Phase 2 Readouts Could Redefine These Biotech Stocks

Upcoming Phase 2 Readouts Could Redefine These Biotech Stocks $NTHI, $ORKA, $ABVX, $CGEM, $SYRE, $APGE

The Biology Came First.

MindWalk Holdings Corp. (NASDAQ: HYFT) today released a systematic report identifying over 20 discovery-originated drug candidates with documented origins in antibody discovery work performed at...

Jennifer Michaelson Sells 8,000 Shares of Cullinan Therapeutics (NASDAQ:CGEM) Stock

Cullinan Therapeutics, Inc. (NASDAQ:CGEM - Get Free Report) insider Jennifer Michaelson sold 8,000 shares of the business's stock in a transaction that occurred on Tuesday, May 5th. The shares were...

Cullinan Therapeutics (NASDAQ:CGEM)  Shares Down 5.6%   - Time to Sell?

Cullinan Therapeutics (NASDAQ:CGEM) Shares Down 5.6% - Here's What Happened...

Cullinan Therapeutics, Inc. (NASDAQ:CGEM) Given Average Rating of "Moderate Buy" by Brokerages

Shares of Cullinan Therapeutics, Inc. (NASDAQ:CGEM - Get Free Report) have been assigned a consensus rating of "Moderate Buy" from the ten analysts that are presently covering the stock, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, one has assigned a h...

Cullinan Therapeutics (NASDAQ:CGEM) Trading 8.5% Higher - Here's Why

Cullinan Therapeutics (NASDAQ:CGEM) Trading Up 8.5% - Time to Buy...

Cullinan Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the developing of oncology and immuno-oncology therapies. Its pipeline includes CLN-978, CLN-619, Zipalertinib CLN-081/TAS6417, CLN-049, and CLN-617. The company was founded by Patrick A. Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA.

Cullinan Therapeutics Inc

Cullinan Therapeutics Stock Slides After-Hours Despite $692M Autoimmune Drug Pact With Genrix

Equity

Neutral Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$21.08
Prev Close	$21.36
Open	$21.38
Dividend Yield	N/A
50-Day Moving Average	$19.64
Beta	1.21
Avg. Volume	688,240.87
PE Ratio	-6.21

52-Week High	$23.19
52-Week Low	$5.68
Market Capitalization	$1.36B
EPS (Annual)	-$3.72
Price to Book	4.23
Revenue Per Employee	$0.00

Feed

News

Sentiment

Earnings

Fundamentals

Info

CGEM Fundamentals